Align Technology, Inc.

  • Are There Investment Opportunities at Your 6-month Teeth Cleaning?

    By Robert Hanley - July 24, 2013 | Tickers: ALGN, XRAY, PDCO

    For most Americans, going to the dentist is right up there with paying taxes as things we don’t particularly look forward to.  Of course, a healthy smile is a useful thing to have, whether you’re going to a job interview or a first date.  The recurring nature of the business and its increasing use of technology make it a fertile ground for investment opportunities.  While the supply distribution more »

  • Three Stocks "Not-to-Buy" After Friday's Earnings

    By Brian Nichols - April 23, 2013 | Tickers: ALGN, IBM, MCD

    Earnings are a great time to capitalize on value, but it is also a time when value investors fall into traps. The key to successfully purchasing a stock after earnings is to assess the company’s value, and in this piece I am looking at three stocks that I believe are not worth the buy after reporting earnings.

    Too Many Questions to Buy this Stock

    International Business Machines (NYSE: IBMmore »)

  • 3 Health Stocks that Look Pretty

    By Alex Bastardas - March 18, 2013 | Tickers: ALGN, AGN, CYNO

    Sales growth in the beauty, personal care, and aesthetic treatment market in the United States doubled the average consumer spending rate growth in 2011 and in 2012. This year will probably not be an exception. In today's image-driven society, people are willing to spend significant amounts of money to look their best. And it's not just women - men are also jumping on the bandwagon, and so are foreign more »

  • Great Companies Making Stuff You Don't Want to Buy

    By Reuben Brewer - December 20, 2012 | Tickers: AFL, ALGN, DG, DLTR

    Every so often you read about so-called “sin” stocks. These corporate bad boys tend be involved in guns, alcohol, and tobacco, among other things. However, these aren't the only companies making things or providing services that are not particularly desirable or that are best avoided. That said, a good deal of money can be made from owning such companies.

  • Keep Smiling With This Company's Strong Growth Prospects

    By Lee Samaha - November 19, 2012 | Tickers: ALGN, HSIC, PDCO, SIRO

    Sirona Dental Systems (NASDAQ: SIRO) delivered another set of results that got investors smiling. I’m a fan of this company and its long term prospects and am somewhat puzzled as to why it doesn’t get more media attention. Its long term growth drivers are an attractive mix of favorable demographics (more old people plus more teeth per person means more restorations) and secular growth from proprietary technological change more »

  • S&P 500 Adds to Gains as Volume Rises Across The Board

    By Joshua Hayes - October 17, 2012 | Tickers: ALGN, AAPL, INTC, IBM, MLNX

    IBM (NYSE: IBM) weighed heavily on the Dow Jones Industrial Average today helping keep the index in negative territory while the S&P 500 and NASDAQ close in the green. Volume on the exchanges was heavier across the board thanks to earnings trading from Intel (NASDAQ: INTC) and IBM. Both stocks were able to find buyers, but failed to get back into positive territory. More trouble for leading growth stocks more »

  • An Overlooked Healthcare Stock that Just Raised Guidance

    By Lee Samaha - August 7, 2012 | Tickers: ALGN, HSIC, PDCO, SI, SIRO

    One of the things that we know we should be doing in equity investing is taking a long term view and, not getting seduced into looking at monthly or quarterly movements. I think this is an argument that should be applied to Sirona Dental Systems (NASDAQ: SIRO). In summary, this is an attractive company with a technological edge in markets with very favorable long term demographics. In true Teutonic style more »

  • Dental Healthcare Stocks Providing Resilient Growth

    By Lee Samaha - May 7, 2012 | Tickers: ALGN, SIRO

    It has been a mixed earnings season for the medical device sector and Sirona Dental Systems (NASDAQ: SIRO) certainly made the picture even more opaque with the results last week. For the other stocks in the sector, this report was quite positive as it indicated that discretionary spending was holding up quite well. However, the relative weakness of non-US & non-European growth versus the rest of the World should be noted more »

  • J.P. Morgan Healthcare Conference Schedule: Day One

    By Brandy Betz - January 8, 2012 | Tickers: ARAY, ACOR, A, ALGN, AMRN, AMGN, AMLN, ARTC, BIIB, BMRN, BRKR, CFN, CTRX, CELG, CNC, COV, DNDN, XRAY, EW, ENDP, EPOC, ESRX, GHDX, GILD, HLS, HTWR, HMSY, HGSI, IDXX, IPXL, INCY, IRWD, MCK, MRX, MDT, MR, MOH, MYL, NVS, ONXX, PRX, PRGO, QSII, REGN, RMD, RIGL, SGEN, ST, SIAL, THC, MDCO, THOR, VRTX, VVUS, WAT, WMGI, ZLTQ

    The 30th Annual J.P. Morgan Healthcare Conference kicks off with a full day of presentations from companies that range from global pharmaceutical leaders to small cap novel pharmaceutical developers and health technology manufacturers. The majority of the presentations will be available through live webcasts with archived replay offered later in the day.

    I will be following (and covering) the novel therapeutic companies that have caught my eye. VIVUS (NASDAQ: VVUSmore »)